Online gaming company Golden Nugget Online is now active on the Nasdaq after blank check entity Landcadia Holdings II (NASDAQ:LCA) purchased at the end of June. The name will eventually be changed to Golden Nugget, and symbol to GNOG.<---- Golden Nugget is owned by the Tilman Fertitta, the CEO of Landry's and owner of the Houston Rockets of the NBA. Golden Nugget customers can wager on NBA games, but not those involving the Rockets. The valuation of Golden Nugget at time of the purchase was $745M. LCA +11% premarket
Limelight Networks, Inc. (LLNW) Got over $8 but the market tanked/ 7.84+0.25 (+3.29%) As of 11:59AM EDT. - With fewer office network connections, that means consumer internet usage will rise. And online video streaming is one of the highest areas of internet data usage growth. There are all sorts of new streaming services, and video delivered via the web is growing increasingly commonplace, according to Limelight Networks. The company operates a modern-day infrastructure network by securely delivering web content for its customers to end-users. Limelight's specialty? Internet video. This is a tiny outfit that dips in and out of positive free cash flow (profitability measured as revenue less cash operating and capital expenses), but it's currently growing fast thanks to the launch of streaming services Disney+ last year and Comcast's Peacock this year. That trend will continue as Limelight's customers rely on it to get video delivered to homes around the globe.
Wow this is crazy stock was a flatline at $10 completely dead and then this Golden Nugget news and it goes to $16 and now retrace to $13<---- Landcadia Holdings II, Inc. (LCA) 13.15+0.85 (+6.91%)
Heavy rains came yesterday. Driveway huge ruts and gashes, outside dirt road all carved up messy...red cones, can barely get out of my driveway in a Mazda and a super huge pooper scooper truck is supposed to come pump out my septic today! You can't make this stuff up... oh and it's 95 degrees today
Good Morning. What day is it? You know you have reached a certain station in life when the pooper scooper man stands you up. I moved all the vehicles up on the lawn. Had to start the damn jeep and drive it almost got rear ended because I cannot stop at the exit point of our road it may stall- I gots to just kind of roar out like 1987 Batman. Several of my indicators are flashing yellow. But i am also wearing a yellow shirt. Ideas For Today) ) ) ) Wish I had a few. HIBB-- is a sporting goods store on my list because of Dick's I sort of compare. HIBB got a price target lift to $30. HIBB is only $21 now-! That could be a nice pick up today in a meh trading environment. Sony announces $250M strategic investment in Epic Games 14:14 KKR, DIS, TCEHY, SNE Sony (SNE) and Epic Games announce that Sony has agreed to make a strategic investment of $250M to acquire a minority interest in Epic through a wholly-owned subsidiary of Sony. "The investment cements an already close relationship between the two companies and reinforces the shared mission to advance the state of the art in technology, entertainment, and socially-connected online services," Sony said. "Epic's powerful technology in areas such as graphics places them at the forefront of game engine development with Unreal Engine and other innovations. There's no better example of this than the revolutionary entertainment experience, Fortnite. Through our investment, we will explore opportunities for further collaboration with Epic to delight and bring value to consumers and the industry at large, not only in games, but also across the rapidly evolving digital entertainment landscape," added Kenichiro Yoshida, Chairman, President and CEO, Sony Corporation. Other investors in Epic include Tencent (TCEHY), Disney (DIS), and KKR (KKR). A Biotech got TWO upgrades today which smells a little fishy on no news and about nine days before an update by the company... Cytokenetics- CYTK As someone who has not worked out since March I can relate to this company and their fight against declining muscle performance This analysis came from realmoney.com it was free on the Net i do not use them. I think it's part of what used to be free at The Street that online rag. Let's take a look at this late-stage bio-pharmaceutical company that is focused on muscle activators and inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. In this daily bar chart of CYTK, below, we can see that prices have tripled since the recent March low. Impressive. Prices are above the rising 50-day moving average line and the rising 200-day moving average line. Notice that the On-Balance-Volume (OBV) turned up back in November and the strong rise in this indicator confirms the big price gains. The trend-following Moving Average Convergence Divergence (MACD) oscillator is positive. In this long-term weekly bar chart of CYTK, below, we used a "log scale" to plot the data. Here we can see a 10 year base pattern. Prices have recently broken out on the upside so we are not too late to the game. Prices are above the rising 40-week moving average line and the weekly OBV line is strong.
There is one more interesting story today. Noah holdings? Yesterday this company went up 7% in a down market. Why? Yesterday this stock had 958,000 shares traded vs a normal 328K why? Look at this-- Noah Holdings Limited Building 2 No. 1687 Changyang Road Changyang Valley Shanghai 200090 China The ole' Building 2.... This is a CHINESE FINANCE company.... Why would Citygroup a respected outfit upgrade because of an expected " Catalyst " that they will not name... City actualy upgraded this name in March-- Noah Holdings upgraded to Buy from Neutral at Citi 03/30/20 NOAH Citi analyst Daphne Poon upgraded Noah Holdings to Buy from Neutral with a price target of $33.50, down from $38.40. The stock's risk/reward is attractive following the 32% year-to-date decline, Poon tells investors in a research note. The analyst finds Noah's progress in standardized product ramp-up is better than expected. Further, concerns over "muted" near-term growth and uncertainties from the Camsing product transformation look to be largely priced in, says Poon. Ok and today the same outfit lifts the target price stays at a buy and mentions an upcoming catalyst.... Stk is $35 up 2 yesterday)))
WATCH: LCA HIBB CYTK NOAH SNY I don't know if this news is enough to move the stock (Ideas For Now portfolio member FTV) but i think it shows a groovy now sort of thinking that I can respect in this business environment. Fortive, Pioneer Square Labs announce creation of TeamSense 11:02 FTV Fortive and Pioneer Square Labs, or "PSL," announced the creation of TeamSense, which they note is the first company formed from their joint innovation studio to create new companies from scratch in the industrial technology space. "TeamSense is launching a secure, turnkey solution that helps employers with hourly workers keep their teams safe and connected during the COVID-19 crisis and beyond. The mobile-based application provides a simple mobile solution to allow employees to self-report symptoms and then take appropriate actions according to their respective company's policies. The solution provides company administrators and front-line supervisors with easy-to-use dashboards and daily rosters to track and report the health status of their workforce at a glance," Fortive and PSL stated.
Adding WMT to watch list (don't ask) --new $140 PT based on healthcare? Morgan Stanley. Walmart on July 8 revealed that it has created an insurance company named ‘Walmart Insurance Services LLC’ to sell Medicare insurance with its groceries and clothing, starting from August. “There is scant detail around Walmart’s overarching health strategy aside from the fact that it wants to improve access to, and reduce the costs of, healthcare in the US.
Remember I told you about the various ongoing trials (3) that could give GILD new press releases: One just came- Gilead Sciences (GILD) -Get Report shares jumped higher Friday after the drugmaker published new data touting the effectiveness of its developing coronavirus treatment. Gilead said patients treated with remdesivir, an investigational antiviral for the treatment of COVID-19, showed improved recoveries in as Phase III study, with a 62% reduction in mortality rates. Gilead said comparative findings from the trial showed that 74.4% of patients treated with remdesivir recovered from the virus by day 14, while the figure for those receiving standard care showed a 59% recovery rate. >> So that's 74% recovery after 14 days is kind of a long stay..... 59% recovered anyway so...I'm just doing the math on my fingers that's only 15 more patients surviving... I think the stock is going up on a first read here and will turn over.